Regulation and Prequalification
Progress towards enhancing regulatory practices related to medical products around the world is supported by capacity building, promoting regulatory convergence and harmonization.

Publications

All →
Department of regulation and prequalification, Strategic Action Plan 2025-2028

WHO’s Department of Regulation and Prequalification strategic action plan (2025–2028) sets out the five strategic priorities that will enable...

Protocol on estimation of Guillain-Barré syndrome background rates in general population in low- and middle-income countries

Background rates of possible adverse events are crucial to monitoring vaccine safety as they help separate potential safety signals following vaccination...

WHO Global Network of National Quality Control Laboratories for Pharmaceuticals: first meeting report, Rio de Janeiro, Brazil, 1-3 October 2024 

The first annual meeting of the World Health Organization (WHO) Global Network of Quality Control Laboratories for Pharmaceuticals (WHO-GNP) was organized...

A case study on the ecosystem for local production of pharmaceuticals, vaccines and biologicals - The Serbia context

The Local Production and Assistance (LPA) Unit in the Regulation and Prequalification Department (RPQ), Access to Medicines and Health Products Division...

Related documents

Cover image of the Call for action "Greener pharmaceuticals regulatory highway"
Call for action on regulatory support for introduction of more sustainable products and services

An effective regulatory system plays a critical role in ensuring the quality of health products, spanning from their development in the laboratory to their...

Newsletters

All →
WHO pharmaceuticals newsletter - No. 1, 2025

The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities...

Report of the 4th joint 
meeting of the WHO Global 
Advisory Committee on 
Vaccine Safety and the 
Advisory Committee on 
Safety of Medicinal Products, 
12–14 November 2024

The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999, and the Advisory Committee on Safety of Medicinal Products (ACSoMP)...